Blindness-Focused LENZ Therapeutics' Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst Says

on MSN ago, source:

LENZ Therapeutics Inc (NASDAQ:LENZ) released topline results from its Phase 3 CLARITY study of two investigational ...

Newly Listed Lenz Therapeutics' Vision Loss Experimental Drug Meets Primary Goal In Late-Stage Study

on MSN ago, source:

LENZ Therapeutics Inc (NASDAQ:LENZ) released topline results from its Phase 3 CLARITY study of two investigational ...

LENZ Therapeutics Inc LENZ

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

LENZ Therapeutics' Late-stage Study Of LNZ100 In Presbyopia Meets Primary Goal; Stock Rises

13d ago, source:

(RTTNews) - LENZ Therapeutics, Inc. (LENZ) Wednesday announced positive results from the Phase 3 CLARITY study of its two drug candidates LNZ100 and LNZ101, for the treatment of presbyopia, the loss ...

LENZ Therapeutics gains as eye therapy succeeds in late-stage trial

on MSN ago, source:

LENZ Therapeutics (LENZ) stock rises after positive results from Phase 3 trials for its lead asset, LNZ100, in treating ...

LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress

26d ago, source: Yahoo Finance

The new combined company will operate under the name LENZ Therapeutics, Inc. and will commence trading on Nasdaq under the ticker symbol "LENZ" on March 22, 2024. "Following the close of this ...

LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials

13d ago, source: Stockhouse

LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

1d ago, source:

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Integer Holdings (ITGR – Research Report) ...

LENZ Therapeutics, Inc. Common Stock (LENZ)

7d ago, source: Nasdaq

Nasdaq provides press releases highlighting valuable information sent out by companies. Here you can find the company’s latest financial figures, contact information, and source version of the ...

LENZ Therapeutics Inc

12d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

LENZ Therapeutics, Inc. (LENZ)

25d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...